Cell Therapeutics' brain cancer drug gets orphan status Reuters via Yahoo! Canada News Tue, 02 Oct 2012 05:52 AM PDT (Reuters) - Cell Therapeutics Inc said U.S. health regulators granted orphan drug status to its brain cancer drug, sending the company's shares up 26 percent in premarket trading. Orphan status, which is granted by the U.S. Food and Drug Administration to drugs that treat diseases affecting fewer than 200,000 people, provides seven years' marketing exclusivity from the date of approval. The ... | Lilly, Boehringer's diabetes drug shows promise Reuters via Yahoo! Canada News Tue, 02 Oct 2012 03:50 AM PDT (Reuters) - Eli Lilly and Co and German drugmaker Boehringer Ingelheim Pharmaceuticals Inc said data from two trials of their experimental diabetes treatment showed the drug reduced blood pressure in patients. Diabetes patients are prone to high blood pressure, which can raise the risk of other health complications. The drug, empagliflozin, is part of a class of drugs called SGLT-2 inhibitors ... | | |
|
No comments:
Post a Comment